High throughput assay for inhibitors of the epidermal growth factor receptor-associated tyrosine kinase

I C King1, M Feng, J J Catino

  • 1Schering-Plough Research Institute, Kenilworth, NJ 07033.

Life Sciences
|January 1, 1993
PubMed

Insights

We developed a new assay to find inhibitors of epidermal growth factor (EGF) receptor tyrosine kinase in whole cells. This high-throughput method uses natural substrates for effective drug discovery.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Epidermal Growth Factor (EGF) receptor tyrosine kinase plays a crucial role in cell signaling.
  • Inhibitors of this kinase are important therapeutic targets for various diseases.
  • Existing assays often use artificial substrates in non-physiological conditions.

Purpose of the Study:

  • To develop a novel colorimetric assay for identifying inhibitors of EGF receptor-associated tyrosine kinase.
  • To establish a high-throughput screening method using intact cells and natural substrates.
  • To facilitate the discovery of novel kinase inhibitors from diverse compound libraries.

Main Methods:

  • A colorimetric assay was developed utilizing intact cells.
  • EGF receptor from treated cells was captured using an anti-EGF receptor antibody.
  • Phosphotyrosine content was quantified using an anti-phosphotyrosine antibody.

Main Results:

  • The assay is quantitative, does not require radioactive substances, and is suitable for high-throughput screening.
  • It can identify inhibitors that lower phosphotyrosine content through various mechanisms within intact cells.
  • The assay uses the natural substrate, offering a more physiologically relevant environment compared to artificial substrate assays.

Conclusions:

  • This assay is a robust, reproducible, and easy-to-perform method for discovering EGF receptor kinase inhibitors.
  • Its compatibility with organic solvents and tissue culture media makes it suitable for screening natural products and synthetic compounds.
  • The assay is particularly valuable for large-scale screening initiatives in drug discovery.